News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,317 Results
Type
Article (88304)
Company Profile (812)
Press Release (786174)
Multimedia
Podcasts (213)
Webinars (34)
Section
Business (233390)
Career Advice (4153)
Deals (39905)
Drug Delivery (161)
Drug Development (91515)
Employer Resources (206)
FDA (18468)
Job Trends (17448)
News (398246)
Policy (40003)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3030)
Academic (2)
Accelerated approval (42)
Adcomms (37)
Allergies (170)
Alliances (56985)
ALS (204)
Alzheimer's disease (1871)
Antibody-drug conjugate (ADC) (405)
Approvals (18682)
Artificial intelligence (721)
Autoimmune disease (240)
Automation (50)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (215)
Biotechnology (486)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (722)
Cancer (5566)
Cardiovascular disease (490)
Career advice (3581)
Career pathing (45)
CAR-T (324)
CDC (70)
Celiac Disease (2)
Cell therapy (902)
Cervical cancer (42)
Clinical research (77708)
Collaboration (2046)
Company closure (6)
Compensation (1287)
Complete response letters (91)
COVID-19 (3011)
CRISPR (110)
C-suite (1025)
Cystic fibrosis (157)
Data (7074)
Decentralized trials (2)
Denatured (79)
Depression (173)
Diabetes (584)
Diagnostics (7390)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (353)
Drug pricing (234)
Drug shortages (36)
Duchenne muscular dystrophy (283)
Earnings (101100)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136299)
Executive appointments (1100)
FDA (21956)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1707)
Gene editing (237)
Generative AI (77)
Gene therapy (748)
GLP-1 (1191)
Government (5496)
Grass and pollen (8)
Guidances (395)
Healthcare (20997)
HIV (80)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (318)
Immuno-oncology (88)
Indications (153)
Infectious disease (3354)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (137)
Intellectual property (278)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (103)
Layoffs (666)
Leadership (44)
Legal (10169)
Liver cancer (102)
Longevity (29)
Lung cancer (744)
Lymphoma (410)
Machine learning (55)
Management (66)
Manufacturing (987)
MASH (191)
Medical device (15130)
Medtech (15211)
Mergers & acquisitions (23086)
Metabolic disorders (1564)
mRNA (211)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (424)
Neuropsychiatric disorders (113)
Neuroscience (3368)
Neurotech (2)
NextGen: Class of 2026 (7712)
Non-profit (5128)
Now hiring (73)
Obesity (763)
Opinion (354)
Ovarian cancer (182)
Pain (242)
Pancreatic cancer (262)
Parkinson's disease (359)
Partnered (39)
Patents (570)
Patient recruitment (594)
Peanut (65)
People (67318)
Pharmaceutical (139)
Pharmacy benefit managers (35)
Phase 1 (24007)
Phase 2 (33728)
Phase 3 (25399)
Pipeline (6851)
Policy (369)
Postmarket research (3554)
Preclinical (10778)
Press Release (72)
Prostate cancer (286)
Psychedelics (61)
Radiopharmaceuticals (325)
Rare diseases (1084)
Real estate (7445)
Recruiting (81)
Regulatory (29536)
Reports (72)
Research institute (2753)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (21)
RSV (95)
Schizophrenia (169)
Series A (290)
Series B (210)
Service/supplier (30)
Sickle cell disease (112)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (51)
Startups (4346)
State (2)
Stomach cancer (21)
Supply chain (126)
Tariffs (101)
The Weekly (131)
Vaccines (1211)
Venture capital (109)
Weight loss (520)
Women's health (113)
Worklife (23)
Date
Today (140)
Last 7 days (685)
Last 30 days (3270)
Last 365 days (32892)
2026 (7645)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (97)
Alaska (7)
Arizona (364)
Arkansas (15)
Asia (51807)
Australia (9103)
California (12606)
Canada (3569)
China (1294)
Colorado (536)
Connecticut (551)
Delaware (379)
Europe (119270)
Florida (1874)
Georgia (407)
Hawaii (4)
Idaho (68)
Illinois (1063)
India (84)
Indiana (588)
Iowa (24)
Japan (492)
Kansas (136)
Kentucky (49)
Louisiana (40)
Maine (85)
Maryland (1562)
Massachusetts (9226)
Michigan (386)
Minnesota (710)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (30)
Nevada (139)
New Hampshire (90)
New Jersey (3377)
New Mexico (33)
New York (3318)
North Carolina (1721)
North Dakota (10)
Northern California (6125)
Ohio (388)
Oklahoma (24)
Oregon (54)
Pennsylvania (2516)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (75)
South Dakota (1)
Southern California (4903)
Tennessee (201)
Texas (2004)
United States (45297)
Utah (379)
Vermont (1)
Virginia (320)
Washington D.C. (88)
Washington State (1042)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
There are 875,317 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
While ersodetug missed the Phase 3 primary endpoint of a reduction in hypoglycemia events, Rezolute argued that this goal was confounded in part by behavioral factors. The FDA acknowledged the validity of this argument.
March 24, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform
March 24, 2026
·
1 min read
Press Releases
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
March 24, 2026
·
1 min read
Press Releases
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
March 24, 2026
·
1 min read
Press Releases
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis
March 24, 2026
·
3 min read
Press Releases
AltaThera Pharmaceuticals Names Dr. Jim Perry as Pediatric Chief Medical Officer
March 24, 2026
·
2 min read
Press Releases
Virchow Raises $4 Million to Advance Biopsy Specimen Stewardship and Expand Access to Precision Oncology
March 24, 2026
·
3 min read
Press Releases
QT Imaging Receives UAE Regulatory Clearance
March 24, 2026
·
6 min read
Press Releases
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
March 24, 2026
·
7 min read
Press Releases
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
March 24, 2026
·
4 min read
1 of 87,532
Next
